{"title":"Five-year survival analysis and predictors of mortality of adult hemodialysis patients in Indonesia: a nationwide database analysis.","authors":"Metalia Puspitasari, Afiatin, Vicka Oktaria, Yulia Wardhani, Wynne Wijaya","doi":"10.1007/s11255-024-04118-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hemodialysis (HD) is the modality of renal replacement therapy (RRT) with the highest mortality rate. The identification of prognostic factors will help achieve better outcomes among HD patients. In this study, we sought to conduct a survival analysis and determine the predictors of mortality among adult Indonesian HD patients using data obtained from Indonesian Renal Registry (IRR).</p><p><strong>Methods: </strong>This is a retrospective cohort study which reviewed all adult hemodialysis patients in Indonesia based on the records of IRR during 2007-2022. Variables analyzed in this study include age, sex, etiology of CKD, cause of death, HD frequency, and initial vascular access. A 5-year follow-up was performed until the outcome of death or drop out was found.</p><p><strong>Results: </strong>Among 99,552 eligible patients, the mean survival length was 1536.21 ± 2.50 days. The 5-year survival rate was 77%. Cox proportional hazard regression model revealed demographic and clinical characteristics that are significantly associated with mortality: male sex (HR: 1.038, 95% CI 1.002-1.075), age of 60 years or older (HR: 1.329, 95% CI 1.281-1.379), diabetic nephropathy (HR: 1.347, 95% CI 1.249-1.452), twice-weekly hemodialysis frequency (HR: 1.080, 95% CI 1.011-1.155), initial vascular accesses with femoral vein puncture (HR: 2.710, 95% CI 2.568-2.860), and CVC (HR: 2.992, 95% CI 2.848-3.144).</p><p><strong>Conclusions: </strong>The 5-year survival rate of Indonesian HD patients is 77. Male sex, age of HD onset at 60 years or older, diabetic nephropathy, twice-weekly HD frequency, and the initial vascular accesses with femoral vein puncture and CVC are associated with increased risk of mortality.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"3657-3664"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Urology and Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11255-024-04118-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/19 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Hemodialysis (HD) is the modality of renal replacement therapy (RRT) with the highest mortality rate. The identification of prognostic factors will help achieve better outcomes among HD patients. In this study, we sought to conduct a survival analysis and determine the predictors of mortality among adult Indonesian HD patients using data obtained from Indonesian Renal Registry (IRR).
Methods: This is a retrospective cohort study which reviewed all adult hemodialysis patients in Indonesia based on the records of IRR during 2007-2022. Variables analyzed in this study include age, sex, etiology of CKD, cause of death, HD frequency, and initial vascular access. A 5-year follow-up was performed until the outcome of death or drop out was found.
Results: Among 99,552 eligible patients, the mean survival length was 1536.21 ± 2.50 days. The 5-year survival rate was 77%. Cox proportional hazard regression model revealed demographic and clinical characteristics that are significantly associated with mortality: male sex (HR: 1.038, 95% CI 1.002-1.075), age of 60 years or older (HR: 1.329, 95% CI 1.281-1.379), diabetic nephropathy (HR: 1.347, 95% CI 1.249-1.452), twice-weekly hemodialysis frequency (HR: 1.080, 95% CI 1.011-1.155), initial vascular accesses with femoral vein puncture (HR: 2.710, 95% CI 2.568-2.860), and CVC (HR: 2.992, 95% CI 2.848-3.144).
Conclusions: The 5-year survival rate of Indonesian HD patients is 77. Male sex, age of HD onset at 60 years or older, diabetic nephropathy, twice-weekly HD frequency, and the initial vascular accesses with femoral vein puncture and CVC are associated with increased risk of mortality.
背景:血液透析(HD)是死亡率最高的肾脏替代治疗(RRT)方式。确定预后因素将有助于改善血液透析患者的预后。在这项研究中,我们试图利用从印度尼西亚肾脏登记处(IRR)获得的数据,对印度尼西亚成年血液透析患者进行生存分析,并确定预测死亡率的因素:这是一项回顾性队列研究,根据 IRR 在 2007-2022 年间的记录,对印尼所有成年血液透析患者进行了回顾。研究分析的变量包括年龄、性别、慢性肾脏病病因、死亡原因、血液透析频率和初始血管通路。研究人员进行了为期 5 年的随访,直至发现死亡或退出的结果:结果:在 99,552 名符合条件的患者中,平均存活时间为(1536.21 ± 2.50)天。5年生存率为77%。Cox 比例危险回归模型显示了与死亡率显著相关的人口统计学和临床特征:男性(HR:1.038,95% CI 1.002-1.075)、60 岁或以上(HR:1.329,95% CI 1.281-1.379)、糖尿病肾病(HR:1.038,95% CI 1.002-1.075)、糖尿病肾病(HR:1.329,95% CI 1.281-1.379)。379)、糖尿病肾病(HR:1.347,95% CI 1.249-1.452)、每周两次血液透析频率(HR:1.080,95% CI 1.011-1.155)、初始血管通路为股静脉穿刺(HR:2.710,95% CI 2.568-2.860)和CVC(HR:2.992,95% CI 2.848-3.144):印度尼西亚 HD 患者的 5 年生存率为 77%。男性性别、60 岁或以上的 HD 发病年龄、糖尿病肾病、每周两次的 HD 频率以及股静脉穿刺和 CVC 的初始血管通路与死亡率风险增加有关。
期刊介绍:
International Urology and Nephrology publishes original papers on a broad range of topics in urology, nephrology and andrology. The journal integrates papers originating from clinical practice.